Remove 2020 Remove Homecare Remove Hospice Remove Personal care
article thumbnail

How Home Health, Personal Care Reimbursement Guiding Addus’ M&A Strategy

Hospice News

As Addus HomeCare Corporation (NASDAQ: ADUS) sinks teeth into acquisitions, the company will be taking smaller bites when it comes to hospice deals. Addus has indicated for roughly the last year that it will orient its M&A strategy towards its home health and personal care services, with hospice becoming less of a priority.

article thumbnail

High Price Tags Pushing Addus Away from Hospice Acquisitions

Hospice News

High valuations have led Addus HomeCare (NASDAQ: ADUS) to pivot towards personal care and home health deals rather than hospice acquisitions. Hospice multiples broke records in 2020, 2021 and 2022, reaching as high as 29x. Hospice is still very expensive. Its hospice business brought in $50.6

Hospice 218
professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Queen City Hospice Expands in Rural Ohio with New Office

Hospice News

Ohio-based Queen City Hospice, an Addus Homecare (NASDAQ: ADUS) company, recently opened a new location in its home state. The new location in Fayetteville, Ohio, adds a central office in a rural region of the hospice’s service area that will reduce staff travel time. Centers for Medicare & Medicaid Services (CMS).

Homecare 222
article thumbnail

What Gentiva’s Expanded Hospice Presence Means for the M&A Mix

Hospice News

Gentiva’s recent $710 million acquisition of ProMedica’s hospice and home-based care assets bucks prevailing trends in today’s M&A market. NYSE: GS), a representative for Gentiva told Hospice News’ sister publication Skilled Nursing News. billion divestiture of Kindred at Home’s hospice and personal care segments.

Hospice 203
article thumbnail

How the 2023 Home Health Rule Could Change the Game in Hospice M&A

Hospice News

The pendulum of investor interest has swung hard into the hospice market in recent years, but shifts in reimbursement could steer buyers towards home health. Uncertainty earlier this year around Medicare’s proposed 2023 home health payment rates led some stakeholders to expect a swerve towards hospice. The initially proposed 4.2%

2023 160
article thumbnail

5 Most Game-Changing Hospice Deals from 2022

Hospice News

Though hospice deal volume dipped in 2022 compared to previous years, five particular transactions could paint a larger picture of where investors see value in the space. These interesting, unusual or groundbreaking deals could signal what’s to come in 2023 and help shape the hospice market’s long-term future. This was Humana Inc.’s

2022 222
article thumbnail

Hospice News’ Top 10 Stories of 2022

Hospice News

In 2022, the hospice community laid the groundwork for a transformational 2023. Centers for Medicare & Medicaid Services (CMS) developed new approaches for enforcing hospice regulations that will become effective on Jan. These trends in value-based care have even influenced the M&A market.

2022 230